Watch our October 2020 briefing, Counterfeit Medicine: Crime and Policy 2020, a summary of the major cases we've seen this year, the trends that worry us, and current drug supply chain policy issues, followed by a ten minute Q&A session with PSM Executive Director Shabbir Imber Safdar.

Counterfeit Medicine: Crime and Policy, October 20, 2020

October 21, 2020

A summary briefing of 2020’s major cases, worrying trends and a deep dive into drug supply chain policy issues.

Counterfeit Medicine News for the Week of October 12, 2020

October 19, 2020
Aaron Shamo Mug Shot

In PSM’s round-up this week: new reports about counterfeit medicine, drug supply chain regulation and phishing scams; FDA warnings about dangerous supplements; a life sentence for fake pill kingpin Aaron Shamo; and more.

“…barriers will delay or prevent drug importation,” say regulatory experts

October 14, 2020

In this analysis, which was published in Lexology on October 13, 2020, three global regulatory experts examine barriers to drug importation.

Counterfeit Medicine News for the Week of October 5, 2020

October 14, 2020

In PSM’s round-up this week: Policy truths about drug importation, prosecutions for fake COVID-19 treatments and financial fraud, and another week in counterfeit pills.

US Attorney for Arizona Calls Illicit Fentanyl “The Most Dangerous Drug We Have Confronted as a Nation”

October 12, 2020

In the first seven months of 2020, the Arizona Department of Health Services reported over 2,700 newly suspected opioid overdose deaths in Arizona. What makes this figure more startling is that there were just over 3,800 suspected opioid deaths in the preceding 30 months. The problem is escalating, and rapidly.

News of the Week

Adopt our Covid Safety campaign!

Post our one pager to your website and to social media. Use the hashtag #covidscams to help raise awareness of criminals using the crisis to prey on people.